• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,009.70 -479.26
( -0.63%)
Global Indices
Nasdaq
50,600.70 294.03
(0.58%)
Dow Jones
7,494.47 27.75
(0.37%)
Hang Seng
64,932.04 -226.15
(-0.35%)
Nikkei 225
10,499.42 33.16
(0.32%)
Forex
USD-INR
95.61 -0.67
(-0.70%)
EUR-INR
110.97 -0.85
(-0.76%)
GBP-INR
128.43 -0.86
(-0.66%)
JPY-INR
0.60 0.00
(-0.79%)

EQUITY - MARKET SCREENER

Natural Capsules Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524654
INE936B01015
166.0913693
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATCAPSUQ
19.26
160.21
EPS(TTM)
Face Value()
Div & Yield %
8.01
10
0
 

sanwaria consumer ltd
Greenlam Industries announces acquisition of balance 33% in its Indonesian subsidiary
Apr 06,2026

Greenlam Asia Pacific, a wholly owned subsidiary of Greenlam Industries in Singapore (Singapore subsidiary) and Greenlam Industries SDN. BHD., a wholly owned subsidiary of Singapore subsidiary in Malaysia (Malaysia subsidiary), have jointly acquired the entire 33% local shareholding of PT. Greenlam Indo Pacific, a subsidiary of Singapore subsidiary in Indonesia (Indonesia subsidiary/ target entity ).

The Singapore subsidiary earlier held 67% shareholding in the target entity. Pursuant to the above acquisition, the collective shareholding of Singapore subsidiary and Malaysia subsidiary now stands at 100%. Consequently, the target entity has become a wholly owned (step-down) subsidiary of Greenlam Industries.